BIOMAT Database Logo BIOMAT Database Logo

[Studies on thrombolytic therapy for venous thrombosis in the extremities--dynamics of plasmin inhibitor and FDP following administration of urokinase (author's transl)]. 1979

S Takeuchi, and T Shiba

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Takeuchi, and T Shiba
[Thrombolytic therapy. Effect of urokinase on experimental thrombosis (author's transl)].
June 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Takeuchi, and T Shiba
[Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
May 1979, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
S Takeuchi, and T Shiba
[Experimental studies on the mode and amount of urokinase administration in thrombolytic therapy (author's transl)].
September 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Takeuchi, and T Shiba
Thrombolytic Therapy Using Urokinase for Management of Central Venous Catheter Thrombosis.
December 2014, Vascular specialist international,
S Takeuchi, and T Shiba
[A case of arterial thrombosis successfully treated with a large dosage of urokinase--study on urokinase administration with special reference to alpha2-plasmin inhibitor (author's transl)].
April 1979, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Takeuchi, and T Shiba
[Deep venous thrombosis of the upper extremities (author's transl)].
November 1976, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
S Takeuchi, and T Shiba
[Urokinase therapy of deep vein thrombosis (author's transl)].
May 1980, Klinische Wochenschrift,
S Takeuchi, and T Shiba
Thrombolytic therapy for venous thrombosis.
December 1987, Annals of vascular surgery,
S Takeuchi, and T Shiba
[Thrombolytic therapy using urokinase: its mechanism and clinical use (author's transl)].
June 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Takeuchi, and T Shiba
[Experimental and clinical studies on oral urokinase and lysyl-plasminogen. Thrombolytic therapy for cerebral thrombosis].
July 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!